---
title: "DC 7703 - Leukemia (except for chronic myelogenous leukemia):"
diagnostic_code: "7703"
body_system: "Hemic and Lymphatic Systems"
cfr_section: "§ 4.117"
canonical: "https://veteranai.co/va-rating-schedule/hemic-and-lymphatic/7703-leukemia-except-for-chronic-myelogenous-leukemia"
source: "https://www.ecfr.gov/current/title-38/section-4.117"
updated: "2026-07-21T21:06:39.638249Z"
---

# DC 7703 - Leukemia (except for chronic myelogenous leukemia):

Rated under § 4.117. Body system: Hemic and Lymphatic Systems.

Otherwise rate residuals under the appropriate diagnostic code(s)

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | When there is active disease or during a treatment phase |
| 0% | Chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, Rai Stage 0 |

## Notes

- Note (1): A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no recurrence, rate on residuals
- Note (2): Evaluate symptomatic chronic lymphocytic leukemia that is at Rai Stage I, II, III, or IV the same as any other leukemia evaluated under this diagnostic code
- Note (3): Evaluate residuals of leukemia or leukemia therapy under the appropriate diagnostic code(s). Myeloproliferative Disorders: (Diagnostic Codes 7704, 7718, 7719)

# Leukemia (Diagnostic Code 7703)

*VA Disability Rating Schedule — 38 CFR § 4.117, Hemic and Lymphatic Systems*

## Understanding This Condition

Leukemia is a condition affecting the hemic and lymphatic systems. Diagnostic Code 7703 covers leukemia **except for chronic myelogenous leukemia**, which is rated separately.

Under this code, the VA generally rates the condition based on whether there is active disease or ongoing treatment. Once treatment has ended and if there is no recurrence, the VA rates any remaining effects—known as residuals—under the appropriate diagnostic code or codes.

## Available Rating Levels

| Rating | What It Reflects |
| ------ | ---------------- |
| **100%** | When there is active disease or during a treatment phase |
| **0%** | Chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, Rai Stage 0 |

## What the VA Looks For

The VA evaluates leukemia based on whether the disease is active, whether you are undergoing treatment, and what residuals may remain afterward. Key points from the rating criteria include:

- **Continuation of the 100% evaluation.** A 100 percent evaluation continues beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures.

- **Mandatory re-examination.** Six months after such treatment is discontinued, the appropriate disability rating is determined by a mandatory VA examination. Any change in evaluation based on that or any subsequent examination is subject to the provisions of § 3.105(e). **If there has been no recurrence, the condition is rated on residuals.**

- **Rating residuals.** Residuals of leukemia or leukemia therapy are evaluated under the appropriate diagnostic code(s). Related myeloproliferative disorders fall under Diagnostic Codes 7704, 7718, and 7719.

- **Chronic lymphocytic leukemia.** Symptomatic chronic lymphocytic leukemia at Rai Stage I, II, III, or IV is evaluated the same as any other leukemia under this diagnostic code. Asymptomatic chronic lymphocytic leukemia or MBL at Rai Stage 0 is evaluated at 0 percent.

---

*This information is drawn from the VA rating schedule under 38 CFR § 4.117, Diagnostic Code 7703. It is provided for general educational purposes and does not guarantee any particular rating outcome.*

Source: https://www.ecfr.gov/current/title-38/section-4.117